National Health Investors (NYSE:NHI) Releases FY24 Earnings Guidance

National Health Investors (NYSE:NHIGet Free Report) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $4.52-4.56 for the period, compared to the consensus estimate of $4.41.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on NHI. StockNews.com cut shares of National Health Investors from a buy rating to a hold rating in a research report on Thursday, April 18th. Wells Fargo & Company lifted their price objective on shares of National Health Investors from $63.00 to $69.00 and gave the company an overweight rating in a research note on Thursday, May 30th. Finally, Truist Financial lifted their price objective on shares of National Health Investors from $58.00 to $65.00 and gave the company a hold rating in a research note on Wednesday, June 26th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, National Health Investors currently has an average rating of Hold and a consensus target price of $62.13.

Check Out Our Latest Research Report on NHI

National Health Investors Stock Performance

Shares of NHI traded up $1.85 during midday trading on Tuesday, hitting $74.33. 220,703 shares of the stock traded hands, compared to its average volume of 165,327. The firm has a market capitalization of $3.23 billion, a PE ratio of 24.50 and a beta of 1.02. The business’s 50 day moving average price is $69.36 and its two-hundred day moving average price is $63.02. National Health Investors has a 1-year low of $48.51 and a 1-year high of $76.65. The company has a debt-to-equity ratio of 0.91, a quick ratio of 13.24 and a current ratio of 13.24.

Insider Buying and Selling

In related news, Director Robert A. Mccabe, Jr. acquired 437 shares of National Health Investors stock in a transaction that occurred on Friday, May 31st. The stock was acquired at an average price of $65.83 per share, with a total value of $28,767.71. Following the completion of the acquisition, the director now directly owns 21,585 shares of the company’s stock, valued at approximately $1,420,940.55. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 7.26% of the company’s stock.

About National Health Investors

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Articles

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.